[1]
Hollanda, L., Monteiro, L. and Melo, A. 2014. Botulinum toxin type A for cephalic cutaneous allodynia in chronic migraine: a randomized, double-blinded, placebo-controlled trial. Neurology International. 6, 4 (Dec. 2014). DOI:https://doi.org/10.4081/ni.2014.5133.